London: Unilever PLC (LON:ULVR) Stock Has Just Had Its Buy Rating Reiterated by Deutsche Bank. Shares now Have a GBX 3250.00 Target

Share

Unilever PLC (LON:ULVR) Rating Reaffirmed

The firm has just set a Estimated Target Price of GBX 3250.00 on Unilever PLC (LON:ULVR) shares. This is 16.07% from the last stock close price. In a note made public on Wednesday morning, Deutsche Bank maintained their Buy rating on shares of ULVR.

From a total of 19 analysts covering Unilever PLC (LON:ULVR) stock, 11 rate it a ”Buy”, 6 a “Sell”, and 6 a ”Hold”. This means that 48% of the ratings are positive. The highest target price is GBX 3300 while the lowest target price is GBX 2500. The mean of all analyst targets is GBX 2970.89 with a 3.67% above today’s (GBX 2822) stock price. Unilever PLC was the topic of 74 analyst reports since July 23, 2015 according to the firm StockzIntelligence Inc. Deutsche Bank maintained shares on December 9 with “Buy” rating. Goldman Sachs maintained shares with “Sell” rating and GBX 2760 target share price in a report from a November 26. Berenberg maintained ULVR stock in a recent report from December 4 with “Buy” rating. JP Morgan maintained the rating on November 24. JP Morgan has a “Underweight” rating and a GBX 2525 price target on shares. Finally, Shore Capital maintained the stock with “Buy” rating in a report issued on a November 30.

The stock closed the day at GBX 2822 during the previous session. It is down 0.11% since May 12, 2015 and is uptrending. It has outperformed by 0.90% the S&P500.

London: Unilever PLC (LON:ULVR) Stock Has Just Had Its Buy Rating Reiterated by Deutsche Bank. Shares now Have a GBX 3250.00 Target

Unilever PLC is engaged in the supply of food, home and personal care products. The company has a market cap of 86.71 billion GBP. The Company’s portfolio ranges from nutritionally balanced foods to indulgent ice creams, soaps, shampoos and household care products. It has 23.11 P/E ratio. The Firm operates through four divisions: Personal Care, Foods, Refreshment and Home Care.

COMMENTS: